Latest Breaking News On - Great point partners - Page 7 : comparemela.com

StockNews com Lowers Puma Biotechnology (NASDAQ:PBYI) to Hold

Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reduced their target price on Puma Biotechnology from $8.00 to $7.00 and set a “buy” rating on the stock in a research report […]

United statesPuma biotechnology company profileGoldman sachs group incGreat point partnersPuma biotechnology incSei investments coVanguard group incPuma biotechnologyGet free reportBiotechnology trading downSachs groupPoint partnersSei investmentsPuma biotechnology dailyNasdaq pbyiStocknews com

4D Molecular Therapeutics, Inc (NASDAQ:FDMT) Receives $39 44 Average PT from Analysts

4D Molecular Therapeutics, Inc (NASDAQ:FDMT) Receives $39 44 Average PT from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nova scotiaUnited statesScott bizilyDavid kirnGoldman sachs groupBlackrock incSecurities exchange commissionGoldman sachs group incRoyal bankJefferies financial groupGreat point partnersD molecular therapeutics incMolecular therapeuticsGet free reportFinancial groupMolecular therapeutics stock

Aerovate Therapeutics, Inc (NASDAQ:AVTE) Insider Sells $106,300 25 in Stock

Aerovate Therapeutics, Inc (NASDAQ:AVTE) Insider Sells $106,300 25 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBenjamint dakeGreat point partnersSecurities exchange commissionJefferies financial groupCrossover managementAerovate therapeutics incWells fargo companyVanguard group incBlackrock incAerovate therapeuticsGet free reportExchange commissionTherapeutics stock downFinancial groupPoint partners

4D Molecular Therapeutics (NASDAQ:FDMT) Given New $58 00 Price Target at Jefferies Financial Group

4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) had its price objective hoisted by Jefferies Financial Group from $30.00 to $58.00 in a research report report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. FDMT has been the topic of a number of other research reports. The Goldman Sachs […]

United statesNova scotiaDavid kirnScott bizilyGoldman sachs groupSecurities exchange commissionD molecular therapeutics incRoyal bankJefferies financial groupBlackrock incGoldman sachs group incGreat point partnersMolecular therapeuticsFree reportModerate buyMolecular therapeutics price

Form PRE 14A Vistagen Therapeutics, For: May 29

Form PRE 14A Vistagen Therapeutics, For: May 29
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPalo altoNew yorkNew canaanSan franciscoSouth san franciscoChen yuJerroldd dotsonShawnk singhMichelle rossMargaretm fitzpatrickReidg adlerMargaret fitzpatrickRobert egenCynthia andersonMaryl rotunno